The European respiratory journal
Telomere-related lung fibrosis is diagnostically heterogeneous but uniformly progressive.
Metabolic consequences of obesity as an "outside in" mechanism of disease severity in asthma.
Incidence and prevalence of idiopathic pulmonary fibrosis in US adults 18-64 years old.
Characterisation of patients with interstitial pneumonia with autoimmune features.
Mast cells in asthma: biomarker and therapeutic target.
Interstitial pneumonia with autoimmune features: the new consensus-based definition for this cohort of patients should be broadened.
Acute exacerbation of idiopathic pulmonary fibrosis: shifting the paradigm.
An official European Respiratory Society/American Thoracic Society research statement: interstitial pneumonia with autoimmune features.
Where do we go from here? Clinical drug development in idiopathic pulmonary fibrosis.
A new era in idiopathic pulmonary fibrosis: considerations for future clinical trials.
